How does the USPTO use the computer readable form (CRF) of the “Sequence Listing”?
The USPTO uses the computer readable form (CRF) of the “Sequence Listing” for several important purposes, as outlined in the MPEP: The information on the computer readable form will be entered into the Office’s database for searching and printing nucleotide and amino acid sequences. This electronic database will also enable the Office to provide published…
Read MoreDoes the USPTO return or preserve the computer readable form (CRF) submitted on read-only optical discs?
No, the USPTO does not permanently preserve or return computer readable forms (CRFs) submitted on read-only optical discs. The MPEP clearly states: The Office does not desire to be bound by a requirement to permanently preserve computer readable forms submitted on read-only optical disc(s) for support, priority or correction purposes. Thus, once use of the…
Read MoreWhat is the preferred method for submitting a “Sequence Listing” to the USPTO?
The USPTO’s preferred method for submitting a “Sequence Listing” is as an ASCII plain text file via the USPTO patent electronic filing system. The MPEP states: Filing the “Sequence Listing” as an ASCII plain text file submitted via the USPTO patent electronic filing system that complies with both 37 CFR 1.821(c) and (e) is the…
Read MoreHow does the USPTO handle confidentiality of sequence data in pending applications?
The USPTO maintains strict confidentiality of sequence data in pending applications, in compliance with 35 U.S.C. 122. The MPEP clarifies: It should be noted that the Office’s database complies with the confidentiality requirement imposed by 35 U.S.C. 122. Unpublished pending application sequences are maintained in the database separately from published or patented sequences. That is,…
Read MoreCan corrections be made to a “Sequence Listing” after submission?
Yes, corrections to a “Sequence Listing” can be made under certain circumstances. The MPEP states: The Office may permit correction of the “Sequence Listing” submitted pursuant to 37 CFR 1.821(c), whether on physical sheets of paper or as a PDF image file, at the least, during the pendency of a given application by reference to…
Read MoreWhat is the requirement for submitting a computer readable copy of the “Sequence Listing”?
According to 37 CFR 1.821(e), a computer readable form (CRF) of the “Sequence Listing” must be submitted in applications filed under 35 U.S.C. 111(a) or in national stage applications submitted under 35 U.S.C. 371. The MPEP states: A separate computer readable form must be submitted via the USPTO patent electronic filing system or on read-only…
Read More